OPNURASIB

UNII:	Q3W0H3V1LQ
Formula:	C₂₉H₂₈ClN₇O
Preferred Substance Name:	OPNURASIB
InChIKey:	AZUYLZMQTIKGSC-UHFFFAOYSA-N
GSRS Full Record:	Q3W0H3V1LQ i

2653994-08-0
1-(6-((4M)-4-(5-CHLORO-6-METHYL-1H-INDAZOL-4-YL)-5- METHYL-3-(1-METHYL-1H-INDAZOL-5-YL)-1H-PYRAZOL-1-YL)-2- AZASPIRO(3.3)HEPTAN-2-YL)PROP-2-EN-1-ONE
1-(6-((4M)-4-(5-CHLORO-6-METHYL-1H-INDAZOL-4-YL)-5-METHYL-3-(1-METHYL-1H-INDAZOL-5-YL)-1H-PYRAZOL-1-YL)-2-AZASPIRO(3.3)HEPTAN-2-YL)PROP-2-EN-1-ONE
1-(6-((4R)-4-(5-CHLORO-6-METHYL-1H-INDAZOL-4-YL)-5-METHYL-3-(1-METHYL-1H-INDAZOL-5-YL)-1H-PYRAZOL-1-YL)-2-AZASPIRO(3.3)HEPT-2-YL)-2-PROPEN-1-ONE
2-PROPEN-1-ONE, 1-(6-((4R)-4-(5-CHLORO-6-METHYL-1H-INDAZOL-4-YL)-5-METHYL-3-(1-METHYL-1H-INDAZOL-5-YL)-1H-PYRAZOL-1-YL)-2-AZASPIRO(3.3)HEPT-2-YL)-
JDQ443
JDQ-443
NVP-JDQ-443
OPNURASIB [INN]
OPNURASIB [USAN]
OPNURASIB [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

OPNURASIB

Synonyms and Mappings

Resources